We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 1.52% | 3.35 | 3.30 | 3.40 | 3.35 | 3.30 | 3.30 | 164,059 | 15:18:31 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 0 | -2.37M | -0.0262 | -1.28 | 3.02M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/11/2020 18:55 | this is finished. only reason for bounce was so called covid drugs. now no needloss making for years to come imoback to 2p, 1p? | scepticalinvestor | |
10/11/2020 18:24 | We are actually doing well compared to most biotechnology stocks . Covid is a small part of our story as we are primarily a cancer drug research company .Full 201 results due in 4 weeks time. Should also hear something from Japan any day now | jungmana | |
10/11/2020 18:24 | We are actually doing well compared to most biotechnology stocks . Covid is a small part of our story as we are primarily a cancer drug research company .Full 201 results due in 4 weeks time. Should also hear something from Japan any day now | jungmana | |
10/11/2020 18:20 | Where it belongs, basically. | dope4holders | |
10/11/2020 17:34 | Hmmmm drip drip Into the teens | yourwrong | |
10/11/2020 16:48 | Fingers crossed. Today wasn't a bad day. Hoping for mid twenties by week end. | rapidlyprogressing | |
10/11/2020 16:44 | So...when you look on Valirxs website under 201, it names a H. Yamaguci...shot in the dark. Could it be - Hideto Yamaguchi Vice President, Chemical & Biological Technology Labs at Astellas Pharma Inc. | teamhanz69 | |
10/11/2020 09:01 | Simple play here if you think Suzy & Co can bring Val up there peers valuations we will 4 bag. Today’s Mcap still way undervalued imho. | 412069 | |
10/11/2020 08:54 | 10,000 shares is correct. Its a token payment for the evaluation. On this occasion the concept was more important than the value. | teamhanz69 | |
10/11/2020 08:30 | HEALTHCARE & PHARMA OCTOBER 27, 202011:52 AMUPDATED 14 DAYS AGO Pfizer says no COVID-19 vaccine data yet, could be week or more before it reports By Michael Erman, Manas Mishra And now LOL News Letter Pfizer’s Covid-19 vaccination prevents 90% of infections - study finds Andrew Quinn 19 hrs ago The data was published on Monday morning and suggests it could provide 90 per cent protection to those who have not tested positive for Covid-19. | thebossman | |
10/11/2020 08:07 | Looks like another Fitbio | forkie 12 | |
10/11/2020 07:49 | Good to see their strategy of licensing in promising oncology projects is being enacted. A clear change from the previous management; they are actually delivering on their promises! | nobbygnome | |
10/11/2020 07:47 | Maybe there's confidence that in the near future the shares will be £2?! One can wish... ;-)"This time next year Rodney...." | lagansider | |
10/11/2020 07:31 | I'll give them 10000 shares :-) | amaretto1 | |
10/11/2020 07:28 | 10,000 shares: misprint? | carlisle44 | |
10/11/2020 07:19 | What's the 10,000 shares bit ?? If they were 200 pence I'd understand | amaretto1 | |
10/11/2020 07:06 | You would like to think this RNS would give the shares a boost - but I thought that one day in October. Anyway, fingers and toes crossed. | 801710245 | |
10/11/2020 07:05 | Spreading our wings !! The 10,000 shares odd bit ? Please explain | amaretto1 | |
10/11/2020 06:21 | Nice blue day ahead | rapidlyprogressing |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions